| Market Cap | 63.72M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -8.13M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -12.00% |
| Sales | 10.6M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -26.00% |
| Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -58.00% |
| Recommedations | - | Quick Ratio | 0.18 | Shares Outstanding | 501.51M | 52W Low Chg | 13.00% |
| Insider Own | 28.25% | ROA | -61.64% | Shares Float | 347.69M | Beta | 1.46 |
| Inst Own | - | ROE | - | Shares Shorted/Prior | -/- | Price | 0.14 |
| Gross Margin | 37.81% | Profit Margin | -76.77% | Avg. Volume | 70,919 | Target Price | - |
| Oper. Margin | -61.96% | Earnings Date | Apr 30 | Volume | 43,200 | Change | 0.07% |
BioHarvest Sciences Inc. operates as a biotechnology company. The company develops botanical synthesis platform technology to grow the ingredients inherent in various fruits and plants without the need to grow the plant itself. The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals. It also operates as a contract development and production organization (CDMO) on behalf of customers seeking various molecules; and as a creator of nutraceutical health and wellness products, which includes dietary supplements. The company's products include VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red grapes. The company operates in Israel and the United States. BioHarvest Sciences Inc. is based in Vancouver, Canada.
